Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2024-03-01
2024-04-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Guanidinoacetic Acid (GAA) Administration in Physically Active Men and Women
NCT01133899
Creatine Supplementation and Cognition
NCT01164020
Load and Hold: Impact of 7-Day Creatine Monohydrate Loading on Breath-Hold Cycling Performance
NCT07233707
Effects of Creatine Supplementation on Renal Function
NCT00465140
Creatine and Perioperative Brain Health
NCT07310043
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supplement
One sachet of supplement before breakfast and dinner
Supplement
Dietary supplement containing creatine and guanidinoacetic acid
Placebo
One sachet of inert compound before breakfast and dinner
Placebo
Inert substance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Supplement
Dietary supplement containing creatine and guanidinoacetic acid
Placebo
Inert substance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Absence of metabolic disorders or other health complications
* Provision of signed informed consent
Exclusion Criteria
* Lack of consent to randomization
* Concurrent participation in other studies
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Novi Sad, Faculty of Sport and Physical Education
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sergej Ostojic
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sergej Ostojic, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Novi Sad
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Applied Bioenergetics Lab at Faculty of Sport and PE
Novi Sad, Vojvodina, Serbia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Watanabe A, Kato N, Kato T. Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res. 2002 Apr;42(4):279-85. doi: 10.1016/s0168-0102(02)00007-x.
Hammett ST, Wall MB, Edwards TC, Smith AT. Dietary supplementation of creatine monohydrate reduces the human fMRI BOLD signal. Neurosci Lett. 2010 Aug 2;479(3):201-5. doi: 10.1016/j.neulet.2010.05.054. Epub 2010 May 24.
Zanini D, Todorovic N, Ostojic SM. Creatine with guanidinoacetic acid improves prefrontal brain oxygenation before, during, and after a cognitive task: A randomized controlled pilot trial. Nutr Health. 2025 Jun;31(2):363-368. doi: 10.1177/02601060241300236. Epub 2024 Nov 21.
Related Links
Access external resources that provide additional context or updates about the study.
Web page of study lab
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-1462-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.